Shanghai Medicilon Inc. (SHA:688202)

China flag China · Delayed Price · Currency is CNY
65.75
-1.80 (-2.66%)
At close: Apr 29, 2026
129.65%
Market Cap 8.89B
Revenue (ttm) 1.16B
Net Income (ttm) -167.83M
Shares Out 131.55M
EPS (ttm) -1.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,614,577
Average Volume 4,203,058
Open 66.00
Previous Close 67.55
Day's Range 65.11 - 67.89
52-Week Range 27.69 - 84.70
Beta 0.98
RSI 51.57
Earnings Date Apr 23, 2026

About Shanghai Medicilon

Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. The company operates in Drug Discovery and Pharmaceutical Research, and Preclinical Research segments. It offers medicinal and analytical chemistry; process development; custom and zoom in synthesis; structural, in vitro, and computational biology; protein expression and purification; protein crystallization; and recombinant kinase preparation services, as well as... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 1,717
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688202
Full Company Profile

Financial Performance

In 2025, Shanghai Medicilon's revenue was 1.16 billion, an increase of 12.08% compared to the previous year's 1.04 billion. Losses were -167.83 million, -49.27% less than in 2024.

Financial Statements

News

There is no news available yet.